Plain-English translation of NCT06332677 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying how certain genes called SUV420H1/2 control fat buildup in the liver. By analyzing tissue samples and health information from people with fatty liver disease, this study aims to understand how these genes work and could lead to better treatments for people whose diet and lifestyle changes alone haven't been enough to prevent the disease from progressing.
Fatty liver disease affects millions of people worldwide and can lead to serious liver damage, cirrhosis, and cancer. There is currently no effective medication for people with advanced disease or those who cannot successfully change their diet and lifestyle. This study seeks to understand the genetic roots of the disease so that new treatments can be developed.
You likely qualify if…
You likely don't qualify if…
This is not a treatment study — researchers will analyze tissue samples and health information you have already provided through earlier studies you participated in. There are no new visits, medications, or procedures required. The study team will compare genetic and fat-related markers in your samples to identify patterns in how these genes affect fatty liver disease.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Italy